A randomized, double-blind, placebo-controlled add-on trial of quetiapine in patients with bipolar disorder and cocaine dependence.

Trial Profile

A randomized, double-blind, placebo-controlled add-on trial of quetiapine in patients with bipolar disorder and cocaine dependence.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Nov 2015

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar I disorders; Cocaine abuse
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2012 Actual end date (1 Dec 2007) added as reported by ClincalTrials.gov.
    • 02 Aug 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 02 Aug 2011 Planned end date (Dec 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top